TSPAN3 inhibitors are a class of chemical compounds designed to target and inhibit the function of TSPAN3, a member of the tetraspanin family of membrane proteins. Tetraspanins, including TSPAN3, play critical roles in organizing the structure of the plasma membrane by forming tetraspanin-enriched microdomains, which act as platforms for various cellular functions. TSPAN3 is involved in processes such as cell signaling, cell adhesion, and migration by interacting with other membrane proteins, including integrins and receptors. By regulating these interactions, TSPAN3 contributes to the coordination of cellular communication and movement. TSPAN3 inhibitors are designed to block these interactions by binding to the protein's transmembrane or extracellular domains, thus preventing it from participating in the formation of protein complexes or interfering with its role in membrane organization.
The chemical design of TSPAN3 inhibitors focuses on achieving high specificity for the protein's functional domains, ensuring that they selectively disrupt TSPAN3 without affecting other tetraspanins or membrane proteins. These inhibitors may contain molecular scaffolds that allow them to bind precisely to regions critical for TSPAN3's function, such as its extracellular loops or transmembrane regions that interact with other proteins. Researchers studying TSPAN3 inhibitors aim to understand how these compounds affect cellular processes dependent on tetraspanin-mediated microdomains, such as cell signaling pathways and adhesion mechanisms. By inhibiting TSPAN3, researchers can gain insights into the role of this protein in maintaining membrane structure and mediating protein interactions. This research also contributes to a broader understanding of how tetraspanins, as a family, regulate cellular behavior and communication through their organizational functions in the plasma membrane.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which is part of signaling pathways that Tetraspanins may be involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, affecting pathways associated with Tetraspanins. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src family kinase inhibitor, potentially affecting Tetraspanin-associated signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Selective inhibitor of Src family kinases, could disrupt signaling involving TSPAN3. | ||||||
2-Bromohexadecanoic acid | 18263-25-7 | sc-251714 sc-251714A | 10 g 50 g | $53.00 $201.00 | 4 | |
Inhibits protein palmitoylation, which could affect TSPAN3 localization and function. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Disrupts lipid rafts, which are important for Tetraspanin function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
GTPase inhibitor that may disrupt endocytosis, a process in which Tetraspanins are involved. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Disrupts Golgi function, potentially affecting Tetraspanin trafficking. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibits protein transport from the ER to the Golgi apparatus, could affect TSPAN3. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
Inhibits neutral sphingomyelinase, potentially affecting Tetraspanin-enriched microdomains. | ||||||